These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 27049725)
1. Human platelets repurposed as vehicles for in vivo imaging of myeloma xenotransplants. Dai L; Gu N; Chen BA; Marriott G Oncotarget; 2016 Apr; 7(16):21076-90. PubMed ID: 27049725 [TBL] [Abstract][Full Text] [Related]
2. Human Nanoplatelets as Living Vehicles for Tumor-Targeted Endocytosis In Vitro and Imaging In Vivo. Dai L; Liu Y; Ding S; Wei X; Chen B J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836127 [TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model]. Wang YD; Hu Y; Zhang L; Huang J; Sun CY Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of anti-brain derived neurotrophic factor monoclonal antibody in human multiple myeloma xenograft animal model. Wang YD; Hu Y; Huang J; Zhang L; Sun CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1069-72. PubMed ID: 18928597 [TBL] [Abstract][Full Text] [Related]
5. Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation. Takagi S; Tsukamoto S; Park J; Johnson KE; Kawano Y; Moschetta M; Liu CJ; Mishima Y; Kokubun K; Manier S; Salem KZ; Huynh D; Sacco A; Forward J; Roccaro AM; Battinelli EM; Ghobrial IM Clin Cancer Res; 2018 May; 24(10):2430-2439. PubMed ID: 29440174 [No Abstract] [Full Text] [Related]
6. NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease. Lawson MA; Paton-Hough JM; Evans HR; Walker RE; Harris W; Ratnabalan D; Snowden JA; Chantry AD PLoS One; 2015; 10(3):e0119546. PubMed ID: 25768011 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of gamma secretase inhibitor on human multiple myeloma xenograft mouse model]. Liu QQ; Liu JL; Guo DM; Teng QL Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):794-7. PubMed ID: 24103879 [TBL] [Abstract][Full Text] [Related]
8. Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms. Wang H; Yang S; Zhou H; Sun M; Du L; Wei M; Luo M; Huang J; Deng H; Feng Y; Huang J; Zhou Y J Hematol Oncol; 2015 Mar; 8():26. PubMed ID: 25886453 [TBL] [Abstract][Full Text] [Related]
9. Reovirus as a viable therapeutic option for the treatment of multiple myeloma. Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466 [TBL] [Abstract][Full Text] [Related]
10. Notch1 overexpression promotes cell growth and tumor angiogenesis in myeloma. Guo D; Li C; Teng Q; Sun Z; Li Y; Zhang C Neoplasma; 2013; 60(1):33-40. PubMed ID: 23067214 [TBL] [Abstract][Full Text] [Related]
11. [Establishment of multiple myeloma mouse models expressing brain derived neurotrophic factor]. Wang YD; Hu Y; Zhang L; Huang J; Sun CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):967-72. PubMed ID: 17956671 [TBL] [Abstract][Full Text] [Related]
12. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF. Ding JH; Yuan LY; Huang RB; Chen GA Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194 [TBL] [Abstract][Full Text] [Related]
13. CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice. Carlo-Stella C; Guidetti A; Di Nicola M; Longoni P; Cleris L; Lavazza C; Milanesi M; Milani R; Carrabba M; Farina L; Formelli F; Gianni AM; Corradini P Exp Hematol; 2006 Jun; 34(6):721-7. PubMed ID: 16728276 [TBL] [Abstract][Full Text] [Related]
14. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells. Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402 [TBL] [Abstract][Full Text] [Related]
15. Fucoidan inhibits angiogenesis induced by multiple myeloma cells. Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597 [TBL] [Abstract][Full Text] [Related]
16. MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment. Gu C; Feng L; Peng H; Yang H; Feng Z; Yang Y Oncotarget; 2016 Jan; 7(4):4559-69. PubMed ID: 26683226 [TBL] [Abstract][Full Text] [Related]
17. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment. Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154 [TBL] [Abstract][Full Text] [Related]
18. In vitro binding of an IgE protein to human platelets. Cines DB; van der Keyl H; Levinson AI J Immunol; 1986 May; 136(9):3433-40. PubMed ID: 3007618 [TBL] [Abstract][Full Text] [Related]
19. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. Baughn LB; Di Liberto M; Wu K; Toogood PL; Louie T; Gottschalk R; Niesvizky R; Cho H; Ely S; Moore MA; Chen-Kiang S Cancer Res; 2006 Aug; 66(15):7661-7. PubMed ID: 16885367 [TBL] [Abstract][Full Text] [Related]
20. A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease. Paton-Hough J; Chantry AD; Lawson MA Bone; 2015 Aug; 77():57-68. PubMed ID: 25868800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]